Device_News

Products

This is the first commercially available test in Canada combining identification and therapeutic guidance information to support Resistance Guided Therapy for management of Mycoplasma genitalium (Mgen). Current Canadian management guidelines...

SpeeDx have successfully started their U.S. journey by joining the Texas Health CoLab in Austin Texas. Chosen for its synergy in supporting progressive and innovative health solutions, the technology hub...

ResistancePlus® GC received clearance from the Australian Therapeutic Goods Administration (TGA) today. Launched in December with CE-IVD mark for sale in Europe, Australian laboratories can now access this world-first diagnostic...

An Australian-developed test for gonorrhoea has been created to help stop the spread of antibiotic resistance and to tailor treatment for patients. The new test can detect patients with strains...